Skip to content
Search
About Us
About Us
Subscribe
News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Home
News
All News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
All Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
All Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
All Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Subscribe
About Us
Home
News
All News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
All Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
All Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
All Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Subscribe
About Us
Search
Winter 2017 - Integrated Care
Download Issue
Share
Up Front
Publisher's Corner
Discoveries in Treatment and Illness Prevention
By Patrick M. Schmidt
Features
Interventions in the Treatment and Prevention of Adult Cancer Cachexia
By
Amy Scanlin, MS
Myths and Facts: Hepatitis B
By
Ronale Tucker Rhodes, MS
Opioid Addiction: Is There a Solution?
By
Meredith Whitmore
Going Up: What’s Behind the Growth in IVIG Demand
By
Keith Berman, MPH, MBA
Healthcare Crisis 2030
By
Trudie Mitschang
BioTrends Watch
Washington Report
CMS Adopts Four Options to Comply with MACRA
HHS Selects Physician Groups for Cancer Care Initiative
HHS Issues Final Rule to Overhaul Managed Medicaid
CMS Finalizes ACO Cost Target Changes
HHS Awards Millions to Improve Healthcare
Reimbursement FAQs
Bundled Payments
Industry News
New Autoimmune Disease Treatments Could Cause Fewer Side Effects
FDA Approves First Human Trial of a Zika Vaccine
Study Finds Influenza Vaccine’s Effectiveness Can Be Improved
Phase II Trial Launched of AAT for the Prevention of Lung Transplant Rejection
Sandoz Launches Generic Version of Crestor
Approval Recommended for Zinplava to Prevent Recurrence of C. Diff
FDA Approves Sandoz’s Erelzi as Biosimilar to Amgen’s Enbrel
FDA Approves Amgen’s Amjevita as a Biosimilar to Humira
FDA Approves Vemlidy to Treat Chronic Hepatitis B Virus Infection
Vaccine for Lung Cancer Approved for Clinical Trial
IDELVION Prevents Bleeds and Reduces Drug Consumption in Hemophilia B Patients
Dusquetide Granted Orphan Drug Status to Treat Life-Threatening Immune Disorder
FDA Approves Cabometyx for Advanced Renal Cell Carcinoma
GSK’s Shingles Vaccine Effective in Adults 70-Plus Years Old
Drug to Treat Autoimmune Hemolytic Anemia Granted FDA Orphan Drug Status
BioFocus
Industry Insight
Toward the Ultimate Cure: Gene Therapy for Severe Combined Immunodeficiency
By Keith Berman, MPH, MBA
Patient Profile
Psoriatic Arthritis: A Patient’s Perspective
By Trudie Mitschang
Physician Profile
Psoriatic Arthritis: A Physician’s Perspective
By Trudie Mitschang
Disease Profile
Update on Respiratory Syncytial Virus
By Ronale Tucker Rhodes, MS
BioSources
BioResearch
Similar Efficacy with Use of Subcutaneous and Intravenous Immunoglobulin in CIDP and MMN: Meta-Analysis
Human Alpha-1 Antitrypsin Improves Early Posttransplant Lung Function in Pig Lung Transplant Model